SCHEMBL7930189

SCHEMBL7930189

Cc1cc(OS(=O)(=O)C(F)(F)F)cc2cc[nH]c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.36
HTR1D P28221 4/20 0.36
HTR1B P28222 4/20 0.36
HSD11B1 P28845 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
HTR2C P28335 1/20 0.33
HTR7 P34969 1/20 0.33
HTR6 P50406 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
CXCR2 P25025 2/20 0.32
IKBKB O14920 2/20 0.32
CHUK O15111 2/20 0.32
CXCR1 P25024 1/20 0.32
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31
NR3C2 P08235 1/20 0.31
AR P10275 1/20 0.31
BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3524823 0.84 HTR1A (0.39) HTR1AHTR1DHTR1BHSD11B1CA1
SCHEMBL30644862 0.78 BRD4 (0.34) BRD4TAF1BRPF1CREBBPCECR2
SCHEMBL18239642 0.78 BRD4 (0.34) BRD4TAF1BRPF1CREBBPCECR2
SCHEMBL5372057 0.74 MEN1 (0.47)
SCHEMBL3946952 0.74 HTR1A (0.49) HTR1AHTR1DHTR1BHSD11B1CA1
SCHEMBL10073222 0.73 CXCR2 (0.40) HTR1AHTR1DHTR1BHSD11B1CA1
Pivalate SCHEMBL30711319 0.72 KMT2A (0.38) IKBKBCHUKKEAP1
SCHEMBL18299637 0.72 PDE2A (0.32) NR3C1PGRBRD4TAF1BRPF1
SCHEMBL6940149 0.71 TDP1 (0.44) HTR1AHTR1DHTR1BHSD11B1CA1
SCHEMBL18299986 0.71 KIF11 (0.38) NR3C1PGRBRD4TAF1BRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228868-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-08 US disclosed
WO-2000006556-A1 SUBSTITUTED OXAZOLINES AS ANTIPROLIFERATIVE AGENTS ABBOTT LABORATORIES (US) 2000-02-10 WO disclosed